tiprankstipranks
Advertisement
Advertisement

AU:AT1 Stock Latest News

Atomo Diagnostics Plans Issue of 5 Million Broker Options on ASX
Company AnnouncementsAtomo Diagnostics Plans Issue of 5 Million Broker Options on ASX
8d ago
AT1
Atomo Diagnostics to Raise Capital via Share Purchase Plan and Placement
PremiumCompany Announcements
Atomo Diagnostics to Raise Capital via Share Purchase Plan and Placement
8d ago
AT1
FDA CLIA Waiver for FebriDx Unlocks Major Growth Opportunity for Atomo’s Pascal Platform
PremiumCompany Announcements
FDA CLIA Waiver for FebriDx Unlocks Major Growth Opportunity for Atomo’s Pascal Platform
8d ago
AT1
Atomo Diagnostics Halts Trading Ahead of Key FDA Decision on FebriDx
PremiumCompany Announcements
Atomo Diagnostics Halts Trading Ahead of Key FDA Decision on FebriDx
12d ago
AT1
Atomo Diagnostics Denies Undisclosed News Behind Share Price Move
PremiumCompany Announcements
Atomo Diagnostics Denies Undisclosed News Behind Share Price Move
12d ago
AT1
Atomo Diagnostics Targets Growth in Decentralized Rapid Testing Market
PremiumCompany AnnouncementsAtomo Diagnostics Targets Growth in Decentralized Rapid Testing Market
1M ago
AT1
Atomo Diagnostics Narrows Half-Year Loss as Revenue Edges Higher
Premium
Company Announcements
Atomo Diagnostics Narrows Half-Year Loss as Revenue Edges Higher
1M ago
AT1
Atomo Wins A$630,000 Order for Government-Backed HIV Self-Testing Program
Premium
Company Announcements
Atomo Wins A$630,000 Order for Government-Backed HIV Self-Testing Program
2M ago
AT1
Atomo Wins Second Major Global Fund–Backed Order for HIV Self-Tests
PremiumCompany Announcements
Atomo Wins Second Major Global Fund–Backed Order for HIV Self-Tests
2M ago
AT1
Atomo Diagnostics Sets Date for Q2 FY26 Results and Investor Webinar
PremiumCompany Announcements
Atomo Diagnostics Sets Date for Q2 FY26 Results and Investor Webinar
2M ago
AT1
Atomo Diagnostics Wins Exclusive Global Licence for Rapid Liver Function Test on Pascal Platform
PremiumCompany Announcements
Atomo Diagnostics Wins Exclusive Global Licence for Rapid Liver Function Test on Pascal Platform
3M ago
AT1
Atomo Wins $502,000 HIV Self-Test Order Backed by Global Fund
PremiumCompany Announcements
Atomo Wins $502,000 HIV Self-Test Order Backed by Global Fund
3M ago
AT1
Atomo Diagnostics Grants Options to Director Following Shareholder Approval
PremiumCompany AnnouncementsAtomo Diagnostics Grants Options to Director Following Shareholder Approval
4M ago
AT1
Atomo Diagnostics Issues New Equity Securities Under Employee Incentive Scheme
Premium
Company Announcements
Atomo Diagnostics Issues New Equity Securities Under Employee Incentive Scheme
4M ago
AT1
Atomo Diagnostics Addresses ASX Query on Unusual Trading Activity
Premium
Company Announcements
Atomo Diagnostics Addresses ASX Query on Unusual Trading Activity
4M ago
AT1
Atomo Diagnostics Adopts Amended Constitution
PremiumCompany Announcements
Atomo Diagnostics Adopts Amended Constitution
5M ago
AT1
Atomo Diagnostics Reports Successful 2025 AGM Results
PremiumCompany Announcements
Atomo Diagnostics Reports Successful 2025 AGM Results
5M ago
AT1
Atomo Diagnostics Highlights Strategic Focus at 2025 AGM
PremiumCompany Announcements
Atomo Diagnostics Highlights Strategic Focus at 2025 AGM
5M ago
AT1
Atomo Diagnostics Advances in Rapid Testing Amid Industry Challenges
PremiumCompany Announcements
Atomo Diagnostics Advances in Rapid Testing Amid Industry Challenges
5M ago
AT1
Atomo Diagnostics Reports Significant Progress and Expansion in Q1 FY26
PremiumCompany AnnouncementsAtomo Diagnostics Reports Significant Progress and Expansion in Q1 FY26
5M ago
AT1
Atomo Diagnostics to Release Q1 FY26 Results and Host Investor Webinar
Premium
Company Announcements
Atomo Diagnostics to Release Q1 FY26 Results and Host Investor Webinar
5M ago
AT1
Atomo Diagnostics Announces Upcoming Annual General Meeting
Premium
Company Announcements
Atomo Diagnostics Announces Upcoming Annual General Meeting
6M ago
AT1

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >